Robert Freedman
Concepts (528)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 69 | 2020 | 544 | 9.340 |
Why?
| Choline | 10 | 2021 | 115 | 3.830 |
Why?
| Nicotinic Agonists | 14 | 2016 | 110 | 3.650 |
Why?
| Receptors, Nicotinic | 34 | 2013 | 309 | 3.600 |
Why?
| Evoked Potentials, Auditory | 35 | 2020 | 212 | 3.000 |
Why?
| Brain | 33 | 2021 | 2540 | 2.810 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 22 | 2016 | 120 | 2.540 |
Why?
| Prenatal Exposure Delayed Effects | 8 | 2021 | 511 | 2.210 |
Why?
| Hot Flashes | 7 | 2014 | 73 | 2.190 |
Why?
| Hippocampus | 27 | 2013 | 747 | 2.180 |
Why?
| Psychotic Disorders | 8 | 2021 | 154 | 2.100 |
Why?
| Sensory Gating | 8 | 2020 | 45 | 2.040 |
Why?
| Psychiatry | 5 | 2018 | 205 | 1.930 |
Why?
| Schizophrenic Psychology | 19 | 2015 | 119 | 1.920 |
Why?
| Neural Inhibition | 16 | 2013 | 165 | 1.850 |
Why?
| Periodicals as Topic | 5 | 2018 | 239 | 1.820 |
Why?
| Pregnancy Complications, Infectious | 4 | 2021 | 301 | 1.760 |
Why?
| Benzylidene Compounds | 7 | 2013 | 28 | 1.740 |
Why?
| Nicotine | 17 | 2013 | 276 | 1.690 |
Why?
| Fetal Development | 8 | 2021 | 263 | 1.500 |
Why?
| Antidepressive Agents | 3 | 2023 | 194 | 1.430 |
Why?
| Chromosomes, Human, Pair 15 | 16 | 2015 | 74 | 1.370 |
Why?
| Ketamine | 2 | 2023 | 104 | 1.360 |
Why?
| Pyridines | 7 | 2013 | 440 | 1.350 |
Why?
| Attention | 17 | 2020 | 443 | 1.340 |
Why?
| Maternal Exposure | 2 | 2019 | 148 | 1.240 |
Why?
| Menopause | 4 | 2014 | 270 | 1.070 |
Why?
| Pursuit, Smooth | 8 | 2007 | 23 | 1.060 |
Why?
| Evoked Potentials | 7 | 2020 | 124 | 1.000 |
Why?
| Gestational Age | 4 | 2021 | 787 | 0.990 |
Why?
| Pregnancy | 16 | 2021 | 5854 | 0.960 |
Why?
| Mental Disorders | 4 | 2021 | 952 | 0.940 |
Why?
| Dietary Supplements | 5 | 2021 | 473 | 0.940 |
Why?
| Child Behavior | 2 | 2016 | 238 | 0.940 |
Why?
| Electroconvulsive Therapy | 1 | 2023 | 8 | 0.930 |
Why?
| Folic Acid | 3 | 2021 | 165 | 0.920 |
Why?
| Acoustic Stimulation | 17 | 2020 | 333 | 0.920 |
Why?
| Body Temperature Regulation | 4 | 2013 | 73 | 0.890 |
Why?
| Prenatal Care | 4 | 2021 | 261 | 0.880 |
Why?
| Humans | 117 | 2023 | 122796 | 0.860 |
Why?
| Reflex, Startle | 3 | 2014 | 67 | 0.850 |
Why?
| Phosphatidylcholines | 3 | 2018 | 136 | 0.830 |
Why?
| Micronutrients | 2 | 2021 | 83 | 0.790 |
Why?
| Infant Behavior | 2 | 2020 | 35 | 0.780 |
Why?
| Child Development | 4 | 2021 | 449 | 0.770 |
Why?
| Neurons | 10 | 2019 | 1345 | 0.750 |
Why?
| Female | 68 | 2021 | 63629 | 0.730 |
Why?
| Smoking | 14 | 2013 | 1556 | 0.720 |
Why?
| Auditory Perception | 7 | 2004 | 112 | 0.710 |
Why?
| Prefrontal Cortex | 3 | 2016 | 280 | 0.700 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2018 | 57 | 0.700 |
Why?
| Hallucinogens | 1 | 2021 | 75 | 0.700 |
Why?
| Saccades | 7 | 2007 | 52 | 0.670 |
Why?
| Editorial Policies | 2 | 2018 | 53 | 0.670 |
Why?
| Perceptual Disorders | 3 | 2005 | 23 | 0.670 |
Why?
| Endophenotypes | 2 | 2015 | 31 | 0.670 |
Why?
| Adult | 49 | 2021 | 32385 | 0.650 |
Why?
| Nootropic Agents | 2 | 2020 | 28 | 0.640 |
Why?
| Hydrocortisone | 1 | 2020 | 315 | 0.640 |
Why?
| Electroencephalography | 9 | 2020 | 408 | 0.620 |
Why?
| Antipsychotic Agents | 7 | 2008 | 197 | 0.610 |
Why?
| Premature Birth | 1 | 2021 | 304 | 0.610 |
Why?
| Depression | 2 | 2023 | 1190 | 0.610 |
Why?
| Problem Behavior | 1 | 2018 | 88 | 0.590 |
Why?
| Infant, Newborn | 8 | 2021 | 5430 | 0.590 |
Why?
| Betacoronavirus | 1 | 2020 | 265 | 0.590 |
Why?
| Male | 71 | 2021 | 59639 | 0.590 |
Why?
| Arousal | 6 | 1993 | 164 | 0.560 |
Why?
| Marijuana Smoking | 1 | 2019 | 222 | 0.550 |
Why?
| Psychological Trauma | 1 | 2016 | 55 | 0.550 |
Why?
| Primary Prevention | 1 | 2018 | 212 | 0.550 |
Why?
| Validation Studies as Topic | 1 | 2015 | 21 | 0.530 |
Why?
| Afferent Pathways | 3 | 2013 | 44 | 0.530 |
Why?
| Magnetic Resonance Imaging | 11 | 2013 | 3264 | 0.530 |
Why?
| Cognition Disorders | 3 | 2010 | 547 | 0.510 |
Why?
| Brain Mapping | 4 | 2013 | 552 | 0.500 |
Why?
| Amygdala | 1 | 2016 | 180 | 0.500 |
Why?
| Cannabis | 1 | 2021 | 389 | 0.490 |
Why?
| Reaction Time | 7 | 2020 | 416 | 0.490 |
Why?
| Aggression | 1 | 2016 | 201 | 0.480 |
Why?
| Genotype | 9 | 2015 | 1943 | 0.480 |
Why?
| Teaching | 1 | 2016 | 241 | 0.470 |
Why?
| C-Reactive Protein | 3 | 2020 | 363 | 0.470 |
Why?
| Phosphorylcholine | 1 | 2013 | 22 | 0.460 |
Why?
| Sleep Apnea Syndromes | 1 | 2014 | 88 | 0.460 |
Why?
| Bungarotoxins | 9 | 2008 | 44 | 0.450 |
Why?
| Mothers | 5 | 2021 | 728 | 0.440 |
Why?
| Double-Blind Method | 6 | 2016 | 1711 | 0.440 |
Why?
| Genetic Linkage | 10 | 2012 | 328 | 0.430 |
Why?
| Neuropsychological Tests | 6 | 2016 | 1072 | 0.420 |
Why?
| Ocular Motility Disorders | 2 | 2004 | 27 | 0.420 |
Why?
| Autism Spectrum Disorder | 1 | 2016 | 350 | 0.410 |
Why?
| Sleep | 3 | 2014 | 722 | 0.410 |
Why?
| Gyrus Cinguli | 3 | 2006 | 69 | 0.400 |
Why?
| Emotions | 2 | 2016 | 524 | 0.400 |
Why?
| Neural Pathways | 3 | 2010 | 289 | 0.390 |
Why?
| Middle Aged | 28 | 2016 | 28563 | 0.380 |
Why?
| Interneurons | 5 | 2001 | 103 | 0.380 |
Why?
| Cognition | 3 | 2016 | 1066 | 0.380 |
Why?
| 5-Hydroxytryptophan | 1 | 2009 | 22 | 0.370 |
Why?
| Dopamine | 7 | 2009 | 250 | 0.360 |
Why?
| Schizotypal Personality Disorder | 2 | 2002 | 11 | 0.360 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2009 | 37 | 0.360 |
Why?
| Infant | 9 | 2021 | 8523 | 0.360 |
Why?
| Sensation Disorders | 2 | 2007 | 33 | 0.350 |
Why?
| Cerebral Cortex | 5 | 2006 | 430 | 0.350 |
Why?
| Thalamus | 2 | 2007 | 83 | 0.350 |
Why?
| Peer Review, Research | 1 | 2009 | 43 | 0.350 |
Why?
| Fetus | 4 | 2021 | 699 | 0.350 |
Why?
| Cocaine-Related Disorders | 2 | 2001 | 110 | 0.350 |
Why?
| Biomedical Research | 1 | 2015 | 630 | 0.340 |
Why?
| Nitric Oxide Synthase | 2 | 2000 | 227 | 0.330 |
Why?
| Body Temperature | 2 | 2007 | 219 | 0.330 |
Why?
| Writing | 1 | 2009 | 90 | 0.330 |
Why?
| Substance Withdrawal Syndrome | 2 | 2007 | 159 | 0.320 |
Why?
| Sensory Aids | 1 | 2007 | 1 | 0.310 |
Why?
| Neurons, Afferent | 2 | 1999 | 92 | 0.310 |
Why?
| Miniaturization | 1 | 2007 | 24 | 0.310 |
Why?
| Humidity | 1 | 2007 | 45 | 0.300 |
Why?
| Neostriatum | 1 | 2007 | 30 | 0.300 |
Why?
| Equipment and Supplies | 1 | 2007 | 44 | 0.300 |
Why?
| Learning | 2 | 2009 | 387 | 0.290 |
Why?
| Sleep, REM | 2 | 2006 | 53 | 0.290 |
Why?
| Contingent Negative Variation | 2 | 2005 | 9 | 0.290 |
Why?
| Biomarkers | 3 | 2015 | 3662 | 0.290 |
Why?
| Phenotype | 7 | 2018 | 3070 | 0.290 |
Why?
| Child of Impaired Parents | 2 | 1996 | 43 | 0.280 |
Why?
| Pedigree | 8 | 2009 | 492 | 0.280 |
Why?
| Acetylcholine | 3 | 2002 | 211 | 0.280 |
Why?
| Genetic Markers | 7 | 2012 | 358 | 0.280 |
Why?
| Ganglionic Stimulants | 1 | 2005 | 10 | 0.280 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2005 | 14 | 0.280 |
Why?
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 12 | 0.280 |
Why?
| Internship and Residency | 1 | 2016 | 1065 | 0.270 |
Why?
| Child | 9 | 2021 | 19561 | 0.270 |
Why?
| Sensation | 3 | 1991 | 46 | 0.270 |
Why?
| Nicotinic Antagonists | 4 | 2008 | 20 | 0.260 |
Why?
| Galvanic Skin Response | 3 | 2013 | 28 | 0.260 |
Why?
| Receptors, Cholinergic | 5 | 2009 | 48 | 0.260 |
Why?
| Time Perception | 1 | 2005 | 23 | 0.260 |
Why?
| Cross-Over Studies | 3 | 2016 | 469 | 0.250 |
Why?
| Animals | 32 | 2021 | 34133 | 0.250 |
Why?
| Eye Movements | 3 | 2013 | 58 | 0.250 |
Why?
| Mice, Inbred C3H | 2 | 2001 | 256 | 0.250 |
Why?
| Image Processing, Computer-Assisted | 4 | 2013 | 739 | 0.240 |
Why?
| Sleep Deprivation | 1 | 2006 | 174 | 0.240 |
Why?
| Child, Preschool | 5 | 2021 | 9755 | 0.240 |
Why?
| Bipolar Disorder | 4 | 2007 | 207 | 0.240 |
Why?
| Genetic Predisposition to Disease | 5 | 2013 | 2359 | 0.230 |
Why?
| Pyramidal Cells | 3 | 2003 | 54 | 0.230 |
Why?
| Norepinephrine | 5 | 1992 | 214 | 0.230 |
Why?
| Mice, Inbred DBA | 2 | 2008 | 185 | 0.230 |
Why?
| Homovanillic Acid | 5 | 1990 | 7 | 0.220 |
Why?
| Promoter Regions, Genetic | 4 | 2003 | 1188 | 0.220 |
Why?
| Linkage Disequilibrium | 2 | 2009 | 279 | 0.210 |
Why?
| Hearing Disorders | 1 | 2001 | 10 | 0.200 |
Why?
| Rats | 16 | 2002 | 5426 | 0.200 |
Why?
| Social Problems | 1 | 2021 | 11 | 0.200 |
Why?
| Publishing | 2 | 2016 | 161 | 0.200 |
Why?
| Vitamin A | 1 | 2021 | 55 | 0.200 |
Why?
| Reward | 1 | 2023 | 214 | 0.200 |
Why?
| Phencyclidine | 3 | 1992 | 4 | 0.200 |
Why?
| Oxygen | 3 | 2013 | 887 | 0.190 |
Why?
| Vitamin D | 2 | 2021 | 363 | 0.190 |
Why?
| Fatty Acids, Omega-3 | 2 | 2021 | 127 | 0.190 |
Why?
| Frontal Lobe | 3 | 2006 | 152 | 0.190 |
Why?
| Sweating | 2 | 2013 | 24 | 0.190 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2004 | 374 | 0.190 |
Why?
| Clozapine | 3 | 2004 | 21 | 0.190 |
Why?
| Object Attachment | 1 | 2020 | 33 | 0.180 |
Why?
| Vitamins | 1 | 2021 | 163 | 0.180 |
Why?
| Gene Expression Regulation | 3 | 2015 | 2491 | 0.180 |
Why?
| Chromosome Mapping | 4 | 2009 | 518 | 0.180 |
Why?
| Schizophrenia, Childhood | 1 | 1999 | 4 | 0.180 |
Why?
| Young Adult | 4 | 2019 | 11094 | 0.170 |
Why?
| Bombesin | 1 | 1999 | 15 | 0.170 |
Why?
| Alleles | 5 | 2009 | 852 | 0.170 |
Why?
| Analysis of Variance | 5 | 2008 | 1329 | 0.170 |
Why?
| Psychiatric Status Rating Scales | 4 | 2005 | 531 | 0.170 |
Why?
| Rats, Sprague-Dawley | 8 | 2002 | 2501 | 0.170 |
Why?
| Pituitary-Adrenal System | 1 | 2020 | 179 | 0.170 |
Why?
| Genetic Variation | 3 | 2003 | 952 | 0.170 |
Why?
| Maternal Age | 1 | 2019 | 124 | 0.170 |
Why?
| Risk Factors | 10 | 2021 | 9381 | 0.170 |
Why?
| Nutritional Status | 1 | 2021 | 306 | 0.170 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2020 | 215 | 0.160 |
Why?
| RNA, Messenger | 7 | 2006 | 2720 | 0.160 |
Why?
| Catecholamines | 3 | 2002 | 103 | 0.160 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2013 | 49 | 0.160 |
Why?
| Psychomotor Performance | 4 | 2005 | 307 | 0.160 |
Why?
| DNA Mutational Analysis | 3 | 2013 | 390 | 0.160 |
Why?
| Reference Values | 6 | 1996 | 789 | 0.160 |
Why?
| History, 21st Century | 1 | 2018 | 177 | 0.160 |
Why?
| Stem Cells | 1 | 2002 | 576 | 0.160 |
Why?
| Dentate Gyrus | 1 | 1997 | 32 | 0.160 |
Why?
| Irritable Mood | 1 | 2018 | 51 | 0.160 |
Why?
| Family | 4 | 2015 | 595 | 0.150 |
Why?
| Urinary Tract Infections | 1 | 2019 | 143 | 0.150 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2002 | 852 | 0.150 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2012 | 2127 | 0.150 |
Why?
| Postmortem Changes | 3 | 2006 | 16 | 0.150 |
Why?
| Dose-Response Relationship, Drug | 4 | 2010 | 1981 | 0.150 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2017 | 32 | 0.150 |
Why?
| Disease Models, Animal | 7 | 2009 | 3799 | 0.150 |
Why?
| Adolescent | 11 | 2017 | 18948 | 0.150 |
Why?
| Neurocognitive Disorders | 1 | 1996 | 25 | 0.140 |
Why?
| Skin Temperature | 2 | 2006 | 17 | 0.140 |
Why?
| Data Interpretation, Statistical | 1 | 1998 | 345 | 0.140 |
Why?
| Chewing Gum | 2 | 2007 | 8 | 0.140 |
Why?
| Treatment Outcome | 2 | 2023 | 9692 | 0.140 |
Why?
| Gene Expression | 5 | 2006 | 1506 | 0.140 |
Why?
| Prepulse Inhibition | 1 | 2015 | 11 | 0.140 |
Why?
| Benzodiazepines | 2 | 2008 | 125 | 0.140 |
Why?
| Vanilmandelic Acid | 4 | 1990 | 4 | 0.130 |
Why?
| Methoxyhydroxyphenylglycol | 4 | 1990 | 11 | 0.130 |
Why?
| Cell Differentiation | 1 | 2002 | 1805 | 0.130 |
Why?
| Cerebrovascular Circulation | 2 | 2007 | 208 | 0.130 |
Why?
| Nitric Oxide | 1 | 2000 | 884 | 0.130 |
Why?
| Pandemics | 2 | 2021 | 1401 | 0.130 |
Why?
| Respiratory Tract Infections | 1 | 2019 | 335 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2020 | 361 | 0.130 |
Why?
| Signal Processing, Computer-Assisted | 2 | 2013 | 146 | 0.130 |
Why?
| Coronavirus Infections | 1 | 2020 | 349 | 0.130 |
Why?
| Postmenopause | 2 | 2007 | 307 | 0.130 |
Why?
| Hot Temperature | 2 | 2007 | 345 | 0.120 |
Why?
| Snoring | 1 | 2014 | 11 | 0.120 |
Why?
| Corpus Striatum | 2 | 1992 | 130 | 0.120 |
Why?
| Twins | 1 | 1996 | 247 | 0.120 |
Why?
| Synapsins | 1 | 1993 | 13 | 0.120 |
Why?
| Synaptophysin | 1 | 1993 | 12 | 0.120 |
Why?
| Clonidine | 1 | 2013 | 21 | 0.120 |
Why?
| Polymorphism, Single-Stranded Conformational | 2 | 2003 | 32 | 0.120 |
Why?
| Sleep Stages | 1 | 1993 | 63 | 0.120 |
Why?
| Brain Tissue Transplantation | 1 | 1992 | 16 | 0.110 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 31 | 0.110 |
Why?
| Perinatal Care | 1 | 2013 | 39 | 0.110 |
Why?
| Polymorphism, Genetic | 4 | 2009 | 666 | 0.110 |
Why?
| Zinc | 1 | 1995 | 266 | 0.110 |
Why?
| Mesencephalon | 1 | 1992 | 57 | 0.110 |
Why?
| gamma-Aminobutyric Acid | 3 | 2003 | 155 | 0.110 |
Why?
| Genomics | 1 | 2018 | 714 | 0.110 |
Why?
| Estrogen Replacement Therapy | 1 | 2013 | 118 | 0.110 |
Why?
| Parasympathetic Nervous System | 1 | 1992 | 24 | 0.110 |
Why?
| Heart Rate | 2 | 2007 | 756 | 0.110 |
Why?
| Functional Laterality | 1 | 2013 | 215 | 0.110 |
Why?
| United States | 3 | 2018 | 13272 | 0.110 |
Why?
| Auditory Pathways | 1 | 1992 | 54 | 0.110 |
Why?
| Pregnancy Complications | 2 | 2019 | 462 | 0.110 |
Why?
| Inflammation | 2 | 2021 | 2598 | 0.110 |
Why?
| Iodine Radioisotopes | 4 | 2001 | 128 | 0.110 |
Why?
| Circadian Rhythm | 2 | 2013 | 414 | 0.110 |
Why?
| Immunity | 1 | 2013 | 130 | 0.110 |
Why?
| Stress, Psychological | 1 | 2020 | 1021 | 0.110 |
Why?
| Gene Frequency | 2 | 2005 | 522 | 0.100 |
Why?
| Severity of Illness Index | 3 | 2015 | 2784 | 0.100 |
Why?
| Memory | 1 | 2013 | 242 | 0.100 |
Why?
| Gene Duplication | 3 | 2015 | 66 | 0.100 |
Why?
| Blood Pressure | 3 | 2007 | 1713 | 0.100 |
Why?
| Synaptic Transmission | 5 | 1999 | 240 | 0.100 |
Why?
| Sleep Apnea, Obstructive | 1 | 2014 | 237 | 0.090 |
Why?
| Case-Control Studies | 4 | 2012 | 3296 | 0.090 |
Why?
| Genetic Association Studies | 1 | 2012 | 383 | 0.090 |
Why?
| Aged | 9 | 2015 | 20495 | 0.090 |
Why?
| Electrophysiology | 5 | 1996 | 205 | 0.090 |
Why?
| Education, Distance | 1 | 2009 | 36 | 0.090 |
Why?
| Electromyography | 2 | 2005 | 334 | 0.090 |
Why?
| Alprazolam | 1 | 1988 | 6 | 0.090 |
Why?
| Anxiety Disorders | 1 | 2012 | 326 | 0.090 |
Why?
| Sequence Deletion | 1 | 2009 | 175 | 0.080 |
Why?
| Diazepam | 1 | 1988 | 25 | 0.080 |
Why?
| Field Dependence-Independence | 1 | 2008 | 4 | 0.080 |
Why?
| Lorazepam | 1 | 1988 | 26 | 0.080 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 84 | 0.080 |
Why?
| Brief Psychiatric Rating Scale | 1 | 2008 | 5 | 0.080 |
Why?
| Parkinson Disease | 1 | 1992 | 346 | 0.080 |
Why?
| Rats, Inbred Strains | 6 | 1992 | 392 | 0.080 |
Why?
| Glycols | 1 | 1988 | 6 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 1004 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4734 | 0.080 |
Why?
| Follow-Up Studies | 2 | 2013 | 4768 | 0.080 |
Why?
| Evoked Potentials, Somatosensory | 1 | 1988 | 33 | 0.080 |
Why?
| Auditory Perceptual Disorders | 2 | 2008 | 13 | 0.080 |
Why?
| Prospective Studies | 1 | 2019 | 6704 | 0.080 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2013 | 1260 | 0.080 |
Why?
| Genes | 2 | 1998 | 231 | 0.080 |
Why?
| Microsatellite Repeats | 2 | 2012 | 147 | 0.080 |
Why?
| Models, Neurological | 2 | 2000 | 228 | 0.070 |
Why?
| Auditory Cortex | 1 | 2007 | 41 | 0.070 |
Why?
| Depressive Disorder | 1 | 1990 | 347 | 0.070 |
Why?
| Diseases in Twins | 1 | 1988 | 181 | 0.070 |
Why?
| Time Factors | 3 | 2005 | 6682 | 0.070 |
Why?
| Monitoring, Ambulatory | 1 | 2007 | 86 | 0.070 |
Why?
| Alcoholism | 2 | 1995 | 725 | 0.070 |
Why?
| Cerebellum | 4 | 1988 | 205 | 0.070 |
Why?
| Drug Administration Schedule | 1 | 2008 | 757 | 0.070 |
Why?
| Telemetry | 1 | 2005 | 33 | 0.070 |
Why?
| Cold Temperature | 1 | 2006 | 136 | 0.070 |
Why?
| Sensitivity and Specificity | 2 | 2007 | 1855 | 0.070 |
Why?
| Genome | 2 | 2006 | 291 | 0.070 |
Why?
| Memory, Short-Term | 1 | 2008 | 250 | 0.070 |
Why?
| Menstrual Cycle | 1 | 2006 | 115 | 0.070 |
Why?
| Sequence Analysis, DNA | 3 | 2003 | 766 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2007 | 1947 | 0.060 |
Why?
| Visual Pathways | 1 | 2005 | 45 | 0.060 |
Why?
| Quetiapine Fumarate | 1 | 2004 | 28 | 0.060 |
Why?
| Parietal Lobe | 1 | 2005 | 47 | 0.060 |
Why?
| Dibenzothiazepines | 1 | 2004 | 20 | 0.060 |
Why?
| Risperidone | 1 | 2004 | 27 | 0.060 |
Why?
| Statistics as Topic | 1 | 2005 | 314 | 0.060 |
Why?
| Internet | 1 | 2009 | 686 | 0.060 |
Why?
| Verbal Behavior | 1 | 2004 | 51 | 0.060 |
Why?
| Area Under Curve | 1 | 2005 | 303 | 0.060 |
Why?
| Dopamine D2 Receptor Antagonists | 1 | 2003 | 5 | 0.060 |
Why?
| Mice | 6 | 2009 | 15888 | 0.060 |
Why?
| Dopamine Antagonists | 1 | 2003 | 22 | 0.060 |
Why?
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 192 | 0.060 |
Why?
| Visual Fields | 1 | 2004 | 79 | 0.060 |
Why?
| Single-Blind Method | 1 | 2004 | 275 | 0.060 |
Why?
| Mental Recall | 2 | 1996 | 185 | 0.060 |
Why?
| Early Diagnosis | 1 | 2005 | 242 | 0.060 |
Why?
| Head | 1 | 2004 | 95 | 0.060 |
Why?
| Pain Measurement | 1 | 2005 | 481 | 0.060 |
Why?
| Administration, Oral | 1 | 2005 | 786 | 0.060 |
Why?
| Action Potentials | 6 | 1993 | 433 | 0.060 |
Why?
| Age of Onset | 2 | 2007 | 479 | 0.060 |
Why?
| Oxygen Consumption | 1 | 2005 | 613 | 0.060 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 242 | 0.060 |
Why?
| Purkinje Cells | 5 | 1988 | 65 | 0.050 |
Why?
| Exons | 3 | 2015 | 310 | 0.050 |
Why?
| Nerve Tissue Proteins | 1 | 2006 | 557 | 0.050 |
Why?
| Chromosome Disorders | 2 | 1999 | 40 | 0.050 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 2001 | 15 | 0.050 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2001 | 19 | 0.050 |
Why?
| Radioligand Assay | 1 | 2001 | 45 | 0.050 |
Why?
| Sex Characteristics | 1 | 2007 | 690 | 0.050 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2001 | 20 | 0.050 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2001 | 43 | 0.050 |
Why?
| Lod Score | 1 | 2001 | 76 | 0.050 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2001 | 64 | 0.050 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2001 | 64 | 0.050 |
Why?
| Chromosome Aberrations | 2 | 1999 | 136 | 0.050 |
Why?
| Cloning, Molecular | 2 | 2000 | 551 | 0.050 |
Why?
| Binding, Competitive | 1 | 2001 | 205 | 0.050 |
Why?
| Movement | 1 | 2004 | 257 | 0.050 |
Why?
| Hallucinations | 1 | 2001 | 31 | 0.050 |
Why?
| Cell Count | 1 | 2001 | 319 | 0.050 |
Why?
| Nutritional Requirements | 1 | 2021 | 83 | 0.050 |
Why?
| Fornix, Brain | 1 | 2000 | 6 | 0.050 |
Why?
| Denervation | 1 | 2000 | 21 | 0.050 |
Why?
| Lymphocytes | 1 | 2002 | 360 | 0.050 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2000 | 48 | 0.050 |
Why?
| Family Health | 1 | 2001 | 201 | 0.050 |
Why?
| Point Mutation | 2 | 1999 | 231 | 0.050 |
Why?
| Multifactorial Inheritance | 1 | 2001 | 142 | 0.050 |
Why?
| Animals, Newborn | 1 | 2002 | 825 | 0.050 |
Why?
| Blotting, Northern | 2 | 2005 | 199 | 0.050 |
Why?
| Blotting, Western | 3 | 2005 | 1225 | 0.040 |
Why?
| Binding Sites | 1 | 2002 | 1247 | 0.040 |
Why?
| Algorithms | 1 | 2007 | 1593 | 0.040 |
Why?
| Fathers | 1 | 1999 | 47 | 0.040 |
Why?
| Cocaine | 1 | 2001 | 157 | 0.040 |
Why?
| Genetic Testing | 1 | 2001 | 400 | 0.040 |
Why?
| Event-Related Potentials, P300 | 1 | 1998 | 18 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 1003 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 3 | 1989 | 493 | 0.040 |
Why?
| Photic Stimulation | 1 | 1999 | 215 | 0.040 |
Why?
| Self Medication | 1 | 1998 | 8 | 0.040 |
Why?
| Cholinergic Agents | 1 | 1998 | 18 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2021 | 257 | 0.040 |
Why?
| Cell Movement | 1 | 2002 | 929 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 1998 | 122 | 0.040 |
Why?
| Heterozygote | 1 | 1998 | 270 | 0.040 |
Why?
| Electric Conductivity | 2 | 1998 | 91 | 0.040 |
Why?
| Genetics, Population | 1 | 1999 | 212 | 0.040 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 4 | 0.040 |
Why?
| Parents | 2 | 2015 | 1256 | 0.040 |
Why?
| Conditioning, Classical | 2 | 2008 | 90 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2001 | 1727 | 0.040 |
Why?
| Leukocytes, Mononuclear | 1 | 2000 | 514 | 0.040 |
Why?
| Memory Disorders | 1 | 1998 | 170 | 0.040 |
Why?
| Electrooculography | 1 | 1996 | 11 | 0.040 |
Why?
| Age Factors | 2 | 2006 | 3114 | 0.040 |
Why?
| In Situ Hybridization | 2 | 2013 | 324 | 0.040 |
Why?
| Base Sequence | 3 | 2009 | 2186 | 0.040 |
Why?
| Risk | 1 | 1999 | 890 | 0.030 |
Why?
| Sensory Thresholds | 1 | 1996 | 31 | 0.030 |
Why?
| Motor Activity | 2 | 1992 | 679 | 0.030 |
Why?
| Nerve Fibers | 1 | 1995 | 88 | 0.030 |
Why?
| Receptors, Glutamate | 1 | 1995 | 20 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 1995 | 71 | 0.030 |
Why?
| Surveys and Questionnaires | 1 | 2007 | 4882 | 0.030 |
Why?
| Placenta | 1 | 2021 | 648 | 0.030 |
Why?
| Nerve Net | 1 | 1998 | 249 | 0.030 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 336 | 0.030 |
Why?
| Siblings | 1 | 2015 | 235 | 0.030 |
Why?
| Aging | 2 | 1999 | 1694 | 0.030 |
Why?
| Dyskinesia, Drug-Induced | 1 | 1994 | 11 | 0.030 |
Why?
| Cholinergic Fibers | 1 | 1993 | 19 | 0.030 |
Why?
| Horseradish Peroxidase | 1 | 1993 | 27 | 0.030 |
Why?
| Orientation | 1 | 1994 | 46 | 0.030 |
Why?
| Neuromuscular Junction | 1 | 1994 | 53 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 1995 | 1021 | 0.030 |
Why?
| Synaptic Vesicles | 1 | 1993 | 38 | 0.030 |
Why?
| Axonal Transport | 1 | 1993 | 21 | 0.030 |
Why?
| Genetic Engineering | 1 | 1994 | 84 | 0.030 |
Why?
| Chronic Disease | 1 | 1999 | 1645 | 0.030 |
Why?
| Temporal Lobe | 1 | 1993 | 93 | 0.030 |
Why?
| Tissue Banks | 1 | 2013 | 20 | 0.030 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 56 | 0.030 |
Why?
| Nomifensine | 1 | 1992 | 3 | 0.030 |
Why?
| Peptides | 1 | 1999 | 893 | 0.030 |
Why?
| DNA Probes | 1 | 2013 | 62 | 0.030 |
Why?
| Habituation, Psychophysiologic | 1 | 1993 | 56 | 0.030 |
Why?
| HLA-A Antigens | 1 | 2013 | 52 | 0.030 |
Why?
| Receptors, sigma | 1 | 1992 | 1 | 0.030 |
Why?
| Poly A | 1 | 1993 | 48 | 0.030 |
Why?
| Levodopa | 1 | 1992 | 25 | 0.030 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1625 | 0.030 |
Why?
| Genes, MHC Class I | 1 | 2013 | 34 | 0.030 |
Why?
| Biogenic Monoamines | 1 | 1992 | 14 | 0.030 |
Why?
| Benzylamines | 1 | 1992 | 40 | 0.030 |
Why?
| Tomography, Emission-Computed | 1 | 1992 | 59 | 0.030 |
Why?
| Tubocurarine | 1 | 1992 | 3 | 0.030 |
Why?
| N-Methylaspartate | 1 | 1992 | 38 | 0.030 |
Why?
| Mecamylamine | 1 | 1992 | 7 | 0.030 |
Why?
| Parasympatholytics | 1 | 1992 | 14 | 0.030 |
Why?
| Sympathomimetics | 1 | 1992 | 26 | 0.030 |
Why?
| Injections, Intraventricular | 1 | 1992 | 74 | 0.030 |
Why?
| Muscles | 1 | 1994 | 336 | 0.030 |
Why?
| Wakefulness | 1 | 1993 | 141 | 0.030 |
Why?
| Microelectrodes | 1 | 1992 | 33 | 0.030 |
Why?
| Nervous System | 1 | 1992 | 67 | 0.030 |
Why?
| Physical Chromosome Mapping | 1 | 2012 | 17 | 0.030 |
Why?
| Temperature | 1 | 1995 | 631 | 0.030 |
Why?
| Genotyping Techniques | 1 | 2012 | 77 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.030 |
Why?
| DNA Replication | 1 | 1993 | 214 | 0.030 |
Why?
| Transcription, Genetic | 1 | 1997 | 1355 | 0.020 |
Why?
| RNA | 2 | 2013 | 854 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 1993 | 408 | 0.020 |
Why?
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 354 | 0.020 |
Why?
| Recombinant Proteins | 1 | 1994 | 1318 | 0.020 |
Why?
| Introns | 2 | 2003 | 236 | 0.020 |
Why?
| Molecular Sequence Data | 3 | 2003 | 2933 | 0.020 |
Why?
| Saccharomyces cerevisiae | 1 | 1994 | 507 | 0.020 |
Why?
| Risk Assessment | 1 | 1999 | 3213 | 0.020 |
Why?
| Adenylate Cyclase Toxin | 1 | 1989 | 8 | 0.020 |
Why?
| Receptors, Dopamine | 1 | 1989 | 13 | 0.020 |
Why?
| Virulence Factors, Bordetella | 1 | 1989 | 20 | 0.020 |
Why?
| Pertussis Toxin | 1 | 1989 | 29 | 0.020 |
Why?
| Blotting, Southern | 1 | 2009 | 68 | 0.020 |
Why?
| Autoanalysis | 1 | 1989 | 6 | 0.020 |
Why?
| Adenylyl Cyclases | 1 | 1989 | 89 | 0.020 |
Why?
| Electrochemistry | 1 | 1989 | 71 | 0.020 |
Why?
| Yohimbine | 1 | 1988 | 9 | 0.020 |
Why?
| Dioxins | 1 | 1988 | 4 | 0.020 |
Why?
| Dioxanes | 1 | 1988 | 8 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 1989 | 151 | 0.020 |
Why?
| Odds Ratio | 1 | 2012 | 1043 | 0.020 |
Why?
| Dihydro-beta-Erythroidine | 1 | 2008 | 3 | 0.020 |
Why?
| Gene Dosage | 1 | 2009 | 139 | 0.020 |
Why?
| Receptors, Adrenergic | 1 | 1988 | 36 | 0.020 |
Why?
| Cell Line | 2 | 2009 | 2785 | 0.020 |
Why?
| Tyramine | 1 | 1988 | 10 | 0.020 |
Why?
| Pulse | 1 | 1988 | 30 | 0.020 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2009 | 319 | 0.020 |
Why?
| Saliva | 1 | 1989 | 215 | 0.020 |
Why?
| Fluphenazine | 1 | 1987 | 5 | 0.020 |
Why?
| Tobacco Use Disorder | 1 | 2010 | 232 | 0.020 |
Why?
| Audiometry, Evoked Response | 1 | 1987 | 15 | 0.020 |
Why?
| Stereoisomerism | 1 | 1987 | 94 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2008 | 416 | 0.020 |
Why?
| Autoradiography | 2 | 1997 | 73 | 0.020 |
Why?
| Mutation | 2 | 2015 | 3493 | 0.020 |
Why?
| Drug Interactions | 1 | 2008 | 356 | 0.020 |
Why?
| Tyrosine | 1 | 1988 | 267 | 0.020 |
Why?
| Depressive Disorder, Major | 1 | 2010 | 309 | 0.020 |
Why?
| Suicide | 1 | 1993 | 498 | 0.020 |
Why?
| Task Performance and Analysis | 1 | 2007 | 170 | 0.020 |
Why?
| ROC Curve | 1 | 2007 | 494 | 0.020 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2006 | 27 | 0.020 |
Why?
| alpha Catenin | 1 | 2005 | 15 | 0.020 |
Why?
| Transcription Factors | 1 | 1994 | 1616 | 0.020 |
Why?
| Microarray Analysis | 1 | 2005 | 124 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 717 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 547 | 0.020 |
Why?
| Nervous System Diseases | 1 | 1987 | 265 | 0.020 |
Why?
| Diagnosis, Differential | 1 | 2007 | 1423 | 0.010 |
Why?
| Fourier Analysis | 1 | 2002 | 42 | 0.010 |
Why?
| Logistic Models | 1 | 2007 | 1995 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1376 | 0.010 |
Why?
| Artifacts | 1 | 2002 | 130 | 0.010 |
Why?
| Sex Factors | 1 | 2006 | 1860 | 0.010 |
Why?
| Diet | 1 | 1988 | 1168 | 0.010 |
Why?
| Contig Mapping | 1 | 1998 | 10 | 0.010 |
Why?
| Genes, Duplicate | 1 | 1998 | 3 | 0.010 |
Why?
| Restriction Mapping | 1 | 1998 | 77 | 0.010 |
Why?
| Receptors, Presynaptic | 1 | 1998 | 6 | 0.010 |
Why?
| Macaca radiata | 1 | 1997 | 16 | 0.010 |
Why?
| Models, Biological | 1 | 2005 | 1756 | 0.010 |
Why?
| Autopsy | 1 | 1997 | 89 | 0.010 |
Why?
| Organ Specificity | 1 | 1997 | 287 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 1996 | 418 | 0.010 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1995 | 35 | 0.010 |
Why?
| Gene Amplification | 1 | 1995 | 98 | 0.010 |
Why?
| Species Specificity | 1 | 1996 | 578 | 0.010 |
Why?
| Isomerases | 1 | 1994 | 8 | 0.010 |
Why?
| Protein Disulfide-Isomerases | 1 | 1994 | 10 | 0.010 |
Why?
| tau Proteins | 1 | 1995 | 80 | 0.010 |
Why?
| Genes, Fungal | 1 | 1994 | 49 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 73 | 0.010 |
Why?
| Glycosylation | 1 | 1994 | 134 | 0.010 |
Why?
| DNA Primers | 1 | 1995 | 540 | 0.010 |
Why?
| Molecular Biology | 1 | 1994 | 58 | 0.010 |
Why?
| Cadaver | 1 | 1995 | 325 | 0.010 |
Why?
| Fungal Proteins | 1 | 1994 | 132 | 0.010 |
Why?
| Genetic Vectors | 1 | 1994 | 310 | 0.010 |
Why?
| DNA | 1 | 1998 | 1401 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1994 | 2123 | 0.010 |
Why?
| Idazoxan | 1 | 1988 | 1 | 0.010 |
Why?
| Phentolamine | 1 | 1988 | 17 | 0.010 |
Why?
| Receptors, Adrenergic, alpha | 1 | 1988 | 33 | 0.010 |
Why?
| Desipramine | 1 | 1988 | 9 | 0.010 |
Why?
| Rats, Inbred F344 | 1 | 1988 | 245 | 0.010 |
Why?
| Receptors, Adrenergic, beta | 1 | 1988 | 146 | 0.000 |
Why?
| Magnesium | 1 | 1987 | 156 | 0.000 |
Why?
| DNA-Binding Proteins | 1 | 1994 | 1384 | 0.000 |
Why?
| Aged, 80 and over | 1 | 1995 | 6845 | 0.000 |
Why?
|
|
Freedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|